Thursday, February 26, 2026 at 5 p.m. ET Revenue -- $49.1 million, up 2% year over year, and above guidance range of $45 million to $47 million.

Total revenue -- $273,000,000 for the year, representing a nine percent increase and achieving a fourth consecutive annual record in line with guidance.

Liquid-Based Test Volume -- Increased by 128%; liquid segment includes SelectMDx, ResolveMDx, and ExoDx.